HB 264 Utah House · 2026 General Session

Prescription Medication Amendments

HB 264 modifies Utah's prescription medication rules to streamline pharmacy operations. It removes the requirement for pharmacies to notify providers when substituting medications (as authorized by the prescription), allows prescription refills to remain valid for two years, and establishes new rules for standing prescriptions issued by the Department of Health and Human Services. Standing prescriptions must be limited to specific conditions, FDA-approved diagnoses, and clinically appropriate treatments. These changes primarily affect pharmacies, patients receiving refills, and healthcare providers who write prescriptions.
Bill status signed all 5 stages cleared
Introduction
Jan 2026
Committee Review
Feb 2026
House Passage
Feb 2026
Senate Passage
Feb 2026
Signed into Law
Mar 2026
Introduced Jan 20, 2026 Signed Mar 17, 2026
Maddy AI version diff · 4 comparisons

What changed between versions

Amended 2/18/2026 15:02:20 Substitute #1 · 5 edits
MODERATE
This bill amends Utah's prescription laws to remove the requirement that pharmacies notify doctors when they substitute generic medications, extend the validity of prescription refills from one year to two years, and update technical definitions regarding drug substitutions and administrative boards.
Scope change
The bill expands the timeframe for prescription refills and removes a specific notification obligation for pharmacists, thereby reducing administrative burdens on pharmacies and increasing flexibility for patients.
REQUIREMENT

Eliminates the mandate for out-of-state mail-order pharmacies to notify patients via telephone or writing when substituting a generic or similar drug product.

Increases the maximum validity period for prescription refills from one year to two years from the original issue date.

DEFINITION

Corrects a typo in the definition of 'Drug product equivalent' by removing a duplicate word.

Updates the name of the federal agency in the text from 'Federal Food and Drug Administration' to 'United States Food and Drug Administration' for consistency.

TECHNICAL

Removes a redundant word ('prior tobefore') in the section regarding seizure disorder medication substitutions.

Floor votes · Senate Feb 19, 2026 · House Feb 6, 2026

How they voted

250
Passed · 4 other
Total votes 29
Feb 19, 2026
D Democratic6
6 Yea
100% Yea
N Forward1
1 Yea
100% Yea
R Republican22
18 Yea 4
81% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
49
Key actions
10
Committee
6
Amendments
3
Mar 17, 2026
Signed into law
Governor Signed
executive
Feb 20, 2026
Lower · Passed
House/ signed by Speaker/ sent for enrolling
lower
Feb 20, 2026
Lower · Passed
Senate/ signed by President/ returned to House
lower
Feb 20, 2026
Upper · Passed
House/ concurs with Senate amendment
upper
Feb 19, 2026
Introduced
Senate/ to House with amendments
lower
Feb 19, 2026
Lower · Passed
Senate/ passed 3rd reading
lower
Feb 18, 2026
Introduced
Senate/ floor amendment
upper
Feb 17, 2026
Upper · Passed
Senate/ committee report favorable [Senate Health and Human Services Committee]
upper
Feb 12, 2026
Upper · Passed
Senate Comm - Favorable Recommendation [Senate Health and Human Services Committee]
upper
Feb 10, 2026
Committee
Senate/ to standing committee [Senate Health and Human Services Committee]
upper
Feb 6, 2026
Introduced
Senate/ 1st reading (Introduced)
upper
Feb 6, 2026
Upper · Passed
House/ passed 3rd reading
upper
Jan 28, 2026
Lower · Passed
House/ comm rpt/ substituted [House Health and Human Services Committee]
lower
Jan 28, 2026
Lower · Passed
House Comm - Favorable Recommendation [House Health and Human Services Committee]
lower
Jan 23, 2026
Committee
House/ to standing committee [House Health and Human Services Committee]
lower
Jan 20, 2026
Introduced
House/ 1st reading (Introduced)
lower
1 primary · 1 co-sponsor

Sponsors